11 Mar GenXys has been featured on the 2019 Digital Health Emerging Rocket list
We are delighted to be included in the 2019 selections for the Digital Health Emerging Rockets. This list profiles technology companies that will lead market breakthroughs by providing tools and services to facilitate better health.
GenXys is a precision prescribing software company tackling a $130 billion global problem. Following early commercial success in Canada, we closed an oversubscribed seed round that will support GenXys plans to expand into new regions to increase patient safety and medication effectiveness whilst reducing healthcare costs with its market-leading precision prescribing software solution.
We are honored to be recognized by the Ready to Rocket business program! Our comprehensive software for precision prescribing will continue enabling precision health for all.
GenXys provides the world’s most comprehensive precision prescribing solutions to solve health care’s most pressing challenges. Our precision prescribing software and pharmacogenetic test can prevent adverse drug reactions, a leading cause of death, and personalize drug selection to increase drug efficacy. Powering every prescription globally with our software improves medication safety, increases drug efficacy and reduces healthcare costs.
To learn more about GenXys visit www.genxys.com